APA (7th ed.) Citation

Y, P., Y, C., SU, K., A, K., H, S., HC, K., . . . YJ, K. (2026). Transarterial radioembolization versus atezolizumab-bevacizumab for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis. Diagnostic and interventional imaging, 107(1), 25. https://doi.org/10.1016/j.diii.2025.09.002

Chicago Style (17th ed.) Citation

Y, Park, et al. "Transarterial Radioembolization Versus Atezolizumab-bevacizumab for the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis." Diagnostic and Interventional Imaging 107, no. 1 (2026): 25. https://doi.org/10.1016/j.diii.2025.09.002.

MLA (9th ed.) Citation

Y, Park, et al. "Transarterial Radioembolization Versus Atezolizumab-bevacizumab for the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis." Diagnostic and Interventional Imaging, vol. 107, no. 1, 2026, p. 25, https://doi.org/10.1016/j.diii.2025.09.002.